Concepedia

Joris Berwaerts

JB

Statistics

Publications

29

Citations

1.6K

H-Index

22

Active since

1997

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Johnson & Johnson (United States)

ZNA Middelheim Hospital

Antwerp University Hospital

Joris Berwaerts is an author at Janssen (United States) specializing in psychopharmacology, pharmacy, and pharmacology.

Publications per year

1997–2023

29

Publications

29

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

Joris Berwaerts, Yanning Liu, Srihari Gopal et al. · JAMA Psychiatry · 2015 · 224 citations

, , +17

A randomized, placebo‐ and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

Eduard Vieta, Isaac Nuamah, Pilar Lim et al. · Bipolar Disorders · 2010 · 122 citations

, , +17

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

Jan K. Buitelaar, Götz‐Erik Trott, Maria Hofecker et al. · The International Journal of Neuropsychopharmacology · 2011 · 112 citations · Full text

, , +15

A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode

Joris Berwaerts, Rama Melkote, Isaac Nuamah et al. · Journal of Affective Disorders · 2012 · 100 citations

, , +13

Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study

Joris Berwaerts, Rosanne Lane, Isaac Nuamah et al. · Journal of Affective Disorders · 2010 · 92 citations

, , +11

1–5 of 29